Sucralfate

Product NDC
48433-226
11-digit product format
484330226
Labeler code
48433
Product ID
48433-226_56bc4a66-18f6-0c11-e063-6294a90a7e26
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sucralfate
Dosage form
SUSPENSION
Route
ORAL
Labeler
Safecor Health, LLC
Application
ANDA217126
Marketing category
ANDA
Marketing start
2026-07-16
Substance
SUCRALFATE
Active strength
1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC], Organometallic Compounds [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217126-001SUCRALFATESUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A217126-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-1384e616aacf4f…
2026-08-18 06:07:402026-07A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-13caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-132680178bc6a6…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217126-001SUCRALFATE1GM/10MLSUSPENSION / ORALAB2024-11-13a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A217126-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A217126-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A217126-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A217126-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A217126-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A217126-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A217126-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A217126-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A217126-001AB12680178bc6a6…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217126-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Sucralfate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SUCRALFATE1 g/10mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
XX73205DH5Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
313123Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
526f6ebc-557c-4c53-8118-1907baa0820aAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SucralfateSUCRALFATESafecor Health, LLC526f6ebc-557c-4c53-8118-1907baa0820a2026-07-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217126
application number: ANDA217126
ndc (product): 48433-226
SucralfateSUCRALFATECosette Pharmaceuticals, Inc.3054ce94-78a2-4da4-8b14-95311b412ab22024-11-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217126
application number: ANDA217126

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
48433-226-404843302264040 CUP, UNIT-DOSE in 1 CASE (48433-226-40) / 10 mL in 1 CUP, UNIT-DOSE (48433-226-10) 2026-07-16NoNoCurrent